Journal of Clinical Pharmacy and Therapeutics

Cover image for Vol. 37 Issue 2

April 2012

Volume 37, Issue 2

Pages 125–248

  1. Commentaries

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. You have free access to this content
      Multi-mechanistic analgesia for opioid-induced hyperalgesia (pages 125–127)

      R. B. Raffa and J. V. Pergolizzi Jr

      Version of Record online: 19 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01264.x

    2. You have free access to this content
  2. Review Articles

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. You have free access to this content
      A review of the possible role of the essential fatty acids and fish oils in the aetiology, prevention or pharmacotherapy of schizophrenia (pages 132–139)

      K. Akter, D. A. Gallo, S. A. Martin, N. Myronyuk, R. T. Roberts, K. Stercula and R. B. Raffa

      Version of Record online: 19 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01265.x

    2. You have free access to this content
  3. Original Articles

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Effect of CYP3A4*1G on the fentanyl consumption for intravenous patient-controlled analgesia after total abdominal hysterectomy in Chinese Han population (pages 153–156)

      Z-L. Dong, H. Li, Q-X. Chen, Y. Hu, S-J. Wu, L-Y. Tang, W-Y. Gong, G-H. Xie and X-M. Fang

      Version of Record online: 29 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01268.x

    2. High-risk antimicrobial prescriptions among ambulatory patients on warfarin (pages 157–160)

      M. A. Lane, S. T. Devine and J. R. McDonald

      Version of Record online: 24 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01270.x

    3. Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain (pages 161–165)

      H. Fortnum, A. J. Lee, B. Rupnik, A. Avery and on behalf of the Yellow Card Study Collaboration

      Version of Record online: 18 MAY 2011 | DOI: 10.1111/j.1365-2710.2011.01273.x

    4. Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia (pages 166–172)

      N. Poolsup, N. Suksomboon, K. Wongyaowarat, B. Rungkanchananon, P. Niyomrat and S. Kongsuwan

      Version of Record online: 18 MAY 2011 | DOI: 10.1111/j.1365-2710.2011.01274.x

    5. Persistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease (pages 173–181)

      L. B. Jordan, F. Vekeman, A. Sengupta, M. Corral, A. Guo and M. S. Duh

      Version of Record online: 18 MAY 2011 | DOI: 10.1111/j.1365-2710.2011.01276.x

    6. Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes (pages 187–195)

      G. Derosa, A. F. G. Cicero, A. D’Angelo, E. Fogari and P. Maffioli

      Version of Record online: 4 AUG 2011 | DOI: 10.1111/j.1365-2710.2011.01280.x

    7. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity (pages 196–203)

      M. M. Miljkovic, S. Dobric and V. Dragojevic-Simic

      Version of Record online: 1 JUL 2011 | DOI: 10.1111/j.1365-2710.2011.01282.x

  4. Pharmacokinetics

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Sub-optimal serum gentamicin concentrations in sickle cell disease patients utilizing the Hartford protocol (pages 212–216)

      A. A. Abusham, A. H. Mohammed, S. S. Alkindi, M. M. Hassan and I. S. Al-Zakwani

      Version of Record online: 19 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01261.x

    2. Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers (pages 221–225)

      W. Mahatthanatrakul, S. Sriwiriyajan, W. Ridtitid, J. Boonleang, M. Wongnawa, N. Rujimamahasan and W. Pipatrattanaseree

      Version of Record online: 26 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01271.x

  5. Pharmacogenetics

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin (pages 232–236)

      L. K. Teh, I. M. Langmia, M. H. Fazleen Haslinda, H. A. Ngow, M. J. Roziah, R. Harun, Z. A. Zakaria and M. Z. Salleh

      Version of Record online: 20 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01262.x

    2. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine (pages 237–241)

      W. R. Wan Rosalina, L. K. Teh, N. Mohamad, A. Nasir, R. Yusoff, A. A. Baba and M. Z. Salleh

      Version of Record online: 5 MAY 2011 | DOI: 10.1111/j.1365-2710.2011.01272.x

  6. Case Reports

    1. Top of page
    2. Commentaries
    3. Review Articles
    4. Original Articles
    5. Pharmacokinetics
    6. Pharmacogenetics
    7. Case Reports
    1. Methotrexate intoxication: the Pharmaceutical Care process reveals a critical error (pages 242–244)

      I. Arnet, V. Bernhardt and K. E. Hersberger

      Version of Record online: 4 APR 2011 | DOI: 10.1111/j.1365-2710.2011.01263.x

    2. Anaphylaxis during the first course of high-dose methotrexate: a case report and literature review (pages 245–248)

      A. Pugi, S. Benemei, M. Vietri, A. Tondo, A. M. Calvani, A. Mugelli, A. Vannacci and F. Lapi

      Version of Record online: 13 MAY 2011 | DOI: 10.1111/j.1365-2710.2011.01275.x

SEARCH

SEARCH BY CITATION